Respiratory syncytial virus infection during infancy and asthma during childhood in the USA (INSPIRE): a population-based, prospective birth cohort study
- PMID: 37086744
- PMCID: PMC10367596
- DOI: 10.1016/S0140-6736(23)00811-5
Respiratory syncytial virus infection during infancy and asthma during childhood in the USA (INSPIRE): a population-based, prospective birth cohort study
Abstract
Background: Early-life severe respiratory syncytial virus (RSV) infection has been associated with the onset of childhood wheezing illnesses. However, the relationship between RSV infection during infancy and the development of childhood asthma is unclear. We aimed to assess the association between RSV infection during infancy and childhood asthma.
Methods: INSPIRE is a large, population-based, birth cohort of healthy infants with non-low birthweight born at term between June and December, 2012, or between June and December, 2013. Infants were recruited from 11 paediatric practices across middle Tennessee, USA. We ascertained RSV infection status (no infection vs infection) in the first year of life using a combination of passive and active surveillance with viral identification through molecular and serological techniques. Children were then followed up prospectively for the primary outcome of 5-year current asthma, which we analysed in all participants who completed 5-year follow-up. Statistical models, which were done for children with available data, were adjusted for child's sex, race and ethnicity, any breastfeeding, day-care attendance during infancy, exposure to second-hand smoke in utero or during early infancy, and maternal asthma.
Findings: Of 1946 eligible children who were enrolled in the study, 1741 (89%) had available data to assess RSV infection status in the first year of life. The proportion of children with RSV infection during infancy was 944 (54%; 95% CI 52-57) of 1741 children. The proportion of children with 5-year current asthma was lower among those without RSV infection during infancy (91 [16%] of 587) than those with RSV infection during infancy (139 [21%] of 670; p=0·016). Not being infected with RSV during infancy was associated with a 26% lower risk of 5-year current asthma than being infected with RSV during infancy (adjusted RR 0·74, 95% CI 0·58-0·94, p=0·014). The estimated proportion of 5-year current asthma cases that could be prevented by avoiding RSV infection during infancy was 15% (95% CI 2·2-26·8).
Interpretation: Among healthy children born at term, not being infected with RSV in the first year of life was associated with a substantially reduced risk of developing childhood asthma. Our findings show an age-dependent association between RSV infection during infancy and childhood asthma. However, to definitively establish causality, the effect of interventions that prevent, delay, or decrease the severity of the initial RSV infection on childhood asthma will need to be studied.
Funding: US National Institutes of Health.
Copyright © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of interests LJA has served on RSV vaccine advisory boards for Bavarian Nordic, Novavax, Daiichi-Sankyo, ClearPath Development Company, ADVI, Pfizer, and Jansen Pharmaceuticals. Through Emory University, LJA's laboratory currently receives funding from Pfizer for RSV surveillance studies in adults, from Advaccine Biopharmacueticals Suzhou for serological studies of RSV vaccine recipients, and from Sciogen for animal studies on RSV vaccines. LJA is a co-inventor on several Centers for Disease Control and Prevention patents on the RSV G protein and its CX3C chemokine motif relative to immune therapy and vaccine development. LJA is also co-inventor on a patent filing for the use of RSV platform virus-like particles with the F protein and G protein for vaccines. TVH has served on a data safety monitoring board for Pfizer and RSV vaccine advisory boards for Sanofi-Pasteur and Pfizer. All other authors declare no competing interests.
Figures




Comment in
-
The link between respiratory syncytial virus infection during infancy and asthma during childhood.Lancet. 2023 May 20;401(10389):1632-1633. doi: 10.1016/S0140-6736(23)00672-4. Epub 2023 Apr 20. Lancet. 2023. PMID: 37086746 No abstract available.
-
The INSPIRE study: RSV infection during infancy.Lancet. 2024 Feb 24;403(10428):728-729. doi: 10.1016/S0140-6736(23)02286-9. Lancet. 2024. PMID: 38401962 No abstract available.
-
The INSPIRE study: RSV infection during infancy.Lancet. 2024 Feb 24;403(10428):729. doi: 10.1016/S0140-6736(23)02287-0. Lancet. 2024. PMID: 38401963 No abstract available.
References
-
- Driscoll AJ, Arshad SH, Bont L, et al. Does respiratory syncytial virus lower respiratory illness in early life cause recurrent wheeze of early childhood and asthma? Critical review of the evidence and guidance for future studies from a World Health Organization-sponsored meeting. Vaccine 2020. - PMC - PubMed
-
- Hartert TV, Wu P, Brunwasser SM. Respiratory syncytial virus and asthma: untying the Gordian knot. The Lancet Respiratory medicine 2021; 9(10): 1092–4. - PubMed
-
- Brunwasser SM, Snyder BM, Driscoll AJ, et al. Assessing the strength of evidence for a causal effect of respiratory syncytial virus lower respiratory tract infections on subsequent wheezing illness: a systematic review and meta-analysis. The Lancet Respiratory medicine 2020; 8(8): 795–806. - PMC - PubMed
-
- Wittig HJ, Glaser J. The relationship between bronchiolitis and childhood asthma; a follow-up study of 100 cases of bronchiolitis. J Allergy 1959; 30(1): 19–23. - PubMed